Michael T. Cullen's Insider Trades & SAST Disclosures

Michael T. Cullen's most recent trade in Panbela Therapeutics Inc. was a trade of 8,333 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 27, 2023.

Share

Note

This is a custom search result for pattern Michael T. Cullen.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Panbela Therapeutics Inc.	Michael T. Cullen	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Mar 2023	8,333	8,333	-		-	Stock Option (right to buy)
Panbela Therapeutics Inc.	Michael T. Cullen	Director, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	04 Oct 2022	247,000	247,000	-		-	Warrants (right to buy)
Panbela Therapeutics Inc.	Michael T. Cullen	Director, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	04 Oct 2022	165,000	369,576 (5%)	2%		-	Common Stock
Panbela Therapeutics Inc.	Michael T. Cullen	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 May 2021	12,368	12,368	-		-	Stock Option (right to buy)
Panbela Therapeutics Inc.	Michael T. Cullen	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 May 2021	4,316	216,811 (3%)	0%		0	Common Stock
Panbela Therapeutics Inc.	Michael T. Cullen	Director, Executive Chairman, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Mar 2021	55,000	55,000	-		-	Employee Stock Option (right to buy)
Panbela Therapeutics Inc.	Michael T. Cullen	Director, Exec. Chairman, Pres. & CEO, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	01 Sep 2020	10,000	207,995 (3%)	0%		-	Common Stock
Panbela Therapeutics Inc.	Michael T. Cullen	Director, Exec. Chairman, Pres. & CEO, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	01 Sep 2020	10,000	10,000	-		-	Warrant (right to buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades